Market Place
Sourcing Support
Jnana Presents JNT-517 Data, Plans 2025 Pivotal Study
04 Sep 2024 //
GLOBENEWSWIRE
Japan`s Otsuka Pharma to pay up to $1.1 bln to acquire Jnana Therapeutics
01 Aug 2024 //
PRESS RELEASE
Nkarta Adds Experienced Leader in Autoimmune R&D
13 Jun 2024 //
GLOBENEWSWIRE
Jnana At RBC Healthcare Conference
08 May 2024 //
GLOBENEWSWIRE
Jnana Therapeutics to Present Preclinical Data on its PKU Program
16 Mar 2023 //
BUSINESSWIRE
Jnana Therapeutics to Participate in Upcoming Investor Conferences
01 Mar 2023 //
BUSINESSWIRE
Jnana Therapeutics Announces FDA Clearance of IND Application for JNT-517
06 Jan 2023 //
PR NEWSWIRE
Jnana Therapeutics to Present at the 41st Annual J.P. Morgan Conference
05 Jan 2023 //
PR NEWSWIRE
Jnana deepens ties with Roche and grabs a new round of funding
16 Nov 2022 //
BIOPHARMADIVE
Jnana Raises $107 M to Advance Lead PKU Program and Progress Pipeline
15 Nov 2022 //
PRNEWSWIRE
Jnana Therapeutics to Present Preclinical Data for its PKU Program at NPKUA 2022
08 Jul 2022 //
PRNEWSWIRE
Jnana Tx to Advance JNT-517 as Oral Treatment for PKU
23 Feb 2022 //
BUSINESSWIRE
Jnana Therapeutics Appoints John Throup, as Senior Vice President
20 Jan 2022 //
BUSINESSWIRE
Jnana nets $50M to push newly unveiled PKU program
19 Aug 2021 //
FIERCEBIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.